Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
AV
Aveanna Healthcare Holdings Inc. Common Stock
AVAH
Mkt Cap
$2.69B
Volume
933.66K
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
AV
AVAH
AV
Aveanna Healthcare Holdings Inc. Common Stock
AVAH
News
·
Can Molina Healthcare Overcome Lower Premiums and Higher MCR in Q3?
Mkt Cap
$2.76B
Volume
933.66K
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Insider
Filings
Can Molina Healthcare Overcome Lower Premiums and Higher MCR in Q3?
Molina Healthcare is projected to report a 60.9% earnings decline in Q3 2026 with revenues falling 4.8%. The company faces multiple headwinds including a 12.7% membership decline (63% drop in Marketplace enrollment), rising medical care ratio to 93%, and falling premium revenues and investment income. The stock has a negative Earnings ESP of -3.30% and Zacks Rank #4 (Sell), making an earnings beat unlikely.
Zacks Investment Research · Oct 16, 2026
Elevance Q3 Earnings Preview: Will Lower Premiums Weigh on Results?
Elevance Health is projected to report Q3 2026 earnings on October 21, 2026, with consensus estimates showing a 22.7% year-over-year EPS decline to $4.66 per share and a 3% revenue decrease. The company faces challenges from declining premiums (-4.9%), reduced Commercial Individual and Medicaid membership, and a significant 23.9% plunge in Health Benefits operating income. Despite these headwinds, total expenses are expected to decline 5.5%, providing some offset.
Zacks Investment Research · Oct 15, 2026
Implied Volatility Surging for Aveanna Healthcare Stock Options
Aveanna Healthcare Holdings Inc. (AVAH) is drawing attention from options traders due to high implied volatility in its December 2026 $2.50 put options, suggesting market expectations for significant price movement. Despite the volatility, the company maintains a Zacks Rank #2 (Buy) rating with recent analyst upgrades to earnings estimates, indicating a potentially developing trade opportunity.
Zacks Investment Research · Oct 14, 2026
Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?
Aveanna Healthcare (AVAH) is highlighted as a compelling value stock opportunity, holding a Zacks Rank #2 (Buy) rating and an 'A' grade for Value. The stock trades at a Forward P/E of 17.55, below its industry average of 18.43, and demonstrates attractive valuation metrics across P/S and P/CF ratios, suggesting it may be undervalued relative to its earnings outlook.
Zacks Investment Research · Oct 12, 2026
Will Aveanna (AVAH) Beat Estimates Again in Its Next Earnings Report?
Aveanna Healthcare (AVAH), a home health care services provider, is highlighted as a stock likely to beat earnings estimates in its upcoming report. The company has a track record of beating earnings in the last two quarters with an average surprise of 33.94%. With a positive Earnings ESP of +3.28% and a Zacks Rank #2 (Buy), analysts suggest the stock has a strong probability of delivering another earnings beat.
Zacks Investment Research · Oct 9, 2026
Ensign Builds More Scale as Financial Flexibility Remains Strong
The Ensign Group expanded its skilled nursing operations by acquiring 20 facilities across Florida, Washington, and Colorado, entering Florida for the first time. With $262.3M in cash, minimal long-term debt of $135.6M, and $591.6M in available credit, the company is well-positioned for continued growth. The acquisitions bring Ensign's total portfolio to 418 healthcare operations across 18 states.
Zacks Investment Research · Oct 6, 2026
Is Aveanna Healthcare (AVAH) Stock Outpacing Its Medical Peers This Year?
Aveanna Healthcare (AVAH) has significantly outperformed the Medical sector year-to-date, returning 56.4% compared to the sector's 2.8% average return. The company holds a Zacks Rank #2 (Buy) with consensus earnings estimates up 23.2% in the past quarter, indicating improved analyst sentiment. Charles River Laboratories (CRL) is another Medical stock outperforming with a 48.4% year-to-date return.
Zacks Investment Research · Sep 30, 2026
Zacks Industry Outlook Highlights DaVita, LifeStance Health, Option Care Health, and Aveanna Healthcare
The Outpatient & Home Healthcare industry is experiencing rapid growth driven by digital transformation, an aging population, and cost-effectiveness advantages. The industry has a Zacks Industry Rank #52 (top 21%) with a forward P/E of 19.1X. Four key stocks are highlighted: LifeStance Health (Rank #2) with 19.7% revenue growth, Option Care Health (Rank #2) with 1.9% revenue growth, Aveanna Healthcare (Rank #2) with 10.6% revenue growth, and DaVita (Rank #3) with 4.7% revenue growth.
Zacks Investment Research · Aug 31, 2026
Aveanna Healthcare Holdings Inc. (AVAH) Hit a 52 Week High, Can the Run Continue?
Aveanna Healthcare (AVAH) has surged 42.6% over the past month and hit a 52-week high of $14, outperforming its sector with a 69.2% year-to-date gain. The company has consistently beaten earnings estimates and carries a Zacks Rank #2 (Buy) with strong Growth and Momentum scores. While trading at a reasonable valuation relative to peers, the stock shows potential for continued gains in the coming weeks and months.
Zacks Investment Research · Aug 28, 2026
Aveanna to Participate in the 2026 Jefferies Healthcare Services and Technology Conference
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) announced that its management team will present at the 2026 Jefferies Healthcare Services and Technology Conference in Nashville on September 15, 2026 at 4:10pm CST, with 1x1 investor meetings also scheduled for that day. A webcast of the presentation will be available on the company's investor relations website.
GlobeNewswire Inc. · Aug 25, 2026
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
AV
AVAH
Aveanna Healthcare Holdings Inc. Common Stock
Buy
Sell
Market
Limit
Soon
AVAH
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any AVAH yet.
Related Tickers
Earnings